Dickersin, Kay

The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations

Hutton, B., Salanti, G., Caldwell, D. M., Chaimani, A., Schmid, C. H., Cameron, C., Ioannidis, J. P. A., Straus, S., Thorlund, K., Jansen, J. P., et al. (2015) · Annals of Internal Medicine

Meta-analysis and systematic reviewsDelphi Technique in Research

Cited by 8,269

SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials

Chan, A.-W., Tetzlaff, J. M., Altman, D. G., Laupacis, A., Gøtzsche, P. C., Krleža-Jerić, K., Hróbjartsson, A., Mann, H., Dickersin, K., Berlin, J. A., et al. (2013) · Annals of Internal Medicine

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 7,363

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials

Chan, A.-W., Tetzlaff, J. M., Gotzsche, P. C., Altman, D. G., Mann, H., Berlin, J. A., Dickersin, K., Hrobjartsson, A., Schulz, K. F., Parulekar, W. R., et al. (2013) · BMJ

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 6,251

The prevention and treatment of missing data in clinical trials

Little, R. J., D'Agostino, R., Cohen, M. L., Dickersin, K., Emerson, S. S., Farrar, J. T., Frangakis, C., Hogan, J. W., Molenberghs, G., Murphy, S. A., et al. (2012) · New England Journal of Medicine

Statistical Methods and Bayesian InferenceStatistical Methods in Clinical Trials

Cited by 1,884

The Existence of Publication Bias and Risk Factors for Its Occurrence

Dickersin, K. (1990) · JAMA: The Journal of the American Medical Association

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 1,417

Publication bias in clinical trials due to statistical significance or direction of trial results

Hopewell, S., Loudon, K., Clarke, M. J., Oxman, A. D., & Dickersin, K. (2009) · Cochrane Database of Systematic Reviews

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 898

Increasing value and reducing waste: addressing inaccessible research

Chan, A.-W., Song, F., Vickers, A., Jefferson, T., Dickersin, K., Gøtzsche, P. C., Krumholz, H. M., Ghersi, D., & van der Worp, H. B. (2014) · The Lancet

Research Data Management PracticesAcademic Publishing and Open Access

Cited by 887

Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed

Robinson, K. A., & Dickersin, K. (2002) · International Journal of Epidemiology

Meta-analysis and systematic reviewsInformation Retrieval and Search Behavior

Cited by 833

Publication bias and clinical trials

Dickersin, K., Chan, S., Chalmersx, T. C., Sacks, H. S., & Smith, H. (1987) · Controlled Clinical Trials

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 715

Registering Clinical Trials

Dickersin, K. (2003) · JAMA

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 512

Publication Bias: The Problem That Won't Go Away

DICKERSIN, K., & MIN, Y. (1993) · Annals of the New York Academy of Sciences

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 427

Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful.

Dickersin, K. (1995) · JAMA: The Journal of the American Medical Association

Glaucoma and retinal disordersAcute Ischemic Stroke Management

Cited by 393

SPIRIT 2013: new guidance for content of clinical trial protocols

Chan, A.-W., Tetzlaff, J. M., Altman, D. G., Dickersin, K., & Moher, D. (2013) · The Lancet

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 298

Development of The Cochrane Collaboration's Central Register of Controlled Clinical Trials

Dickersin, K., Manheimer, E., Wieland, S., Robinson, K. A., Lefebvre, C., & McDonald, S. (2002) · Evaluation & the Health Professions

Meta-analysis and systematic reviewsscientometrics and bibliometrics research

Cited by 198

ACCF/AHA Clinical Practice Guideline Methodology Summit Report

Jacobs, A. K., Kushner, F. G., Ettinger, S. M., Guyton, R. A., Anderson, J. L., Ohman, E. M., Albert, N. M., Antman, E. M., Arnett, D. K., Bertolet, M., et al. (2013) · Journal of the American College of Cardiology

Clinical practice guidelines implementationDelphi Technique in Research

Cited by 175

Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study

Dechartres, A., Trinquart, L., Atal, I., Moher, D., Dickersin, K., Boutron, I., Perrodeau, E., Altman, D. G., & Ravaud, P. (2017) · BMJ

Meta-analysis and systematic reviewsAcademic Publishing and Open Access

Cited by 171

Multiple outcomes and analyses in clinical trials create challenges for interpretation and research synthesis

Mayo-Wilson, E., Fusco, N., Li, T., Hong, H., Canner, J. K., & Dickersin, K. (2017) · Journal of Clinical Epidemiology

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 131

The Evolution of Trial Registries and Their Use to Assess the Clinical Trial Enterprise

Dickersin, K. (2012) · JAMA

Pharmaceutical industry and healthcareMeta-analysis and systematic reviews

Cited by 127

Practical guidance for using multiple data sources in systematic reviews and meta‐analyses (with examples from the MUDS study)

Mayo‐Wilson, E., Li, T., Fusco, N., Dickersin, K., & for the MUDS investigators (2018) · Research Synthesis Methods

Meta-analysis and systematic reviewsDelphi Technique in Research

Cited by 114

Harms are assessed inconsistently and reported inadequately Part 2: nonsystematic adverse events

Mayo-Wilson, E., Fusco, N., Li, T., Hong, H., Canner, J. K., Dickersin, K., Bertizzolo, L., Cowley, T., Doshi, P., Ehmsen, J., et al. (2019) · Journal of Clinical Epidemiology

Pharmacovigilance and Adverse Drug ReactionsPharmaceutical industry and healthcare

Cited by 109

Cherry-picking by trialists and meta-analysts can drive conclusions about intervention efficacy

Mayo-Wilson, E., Li, T., Fusco, N., Bertizzolo, L., Canner, J. K., Cowley, T., Doshi, P., Ehmsen, J., Gresham, G., Guo, N., et al. (2017) · Journal of Clinical Epidemiology

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 108

Design, Analysis, and Reporting of Crossover Trials for Inclusion in a Meta-Analysis

Li, T., Yu, T., Hawkins, B. S., & Dickersin, K. (2015) · PLOS ONE

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 107

Consumer involvement in systematic reviews of comparative effectiveness research

Kreis, J., Puhan, M. A., Schünemann, H. J., & Dickersin, K. (2013) · Health Expectations

Mental Health and Patient InvolvementMeta-analysis and systematic reviews

Cited by 88

Harms are assessed inconsistently and reported inadequately part 1: systematic adverse events

Mayo-Wilson, E., Fusco, N., Li, T., Hong, H., Canner, J. K., Dickersin, K., Bertizzolo, L., Cowley, T., Doshi, P., Ehmsen, J., et al. (2019) · Journal of Clinical Epidemiology

Pharmacovigilance and Adverse Drug ReactionsPharmaceutical industry and healthcare

Cited by 63